{"product_id":"viral-vectors-in-veterinary-vaccine-development-a-textbook","title":"Viral Vectors In Veterinary Vaccine Development A Textbook","description":"\u003cp\u003eViral Vectors In Veterinary Vaccine Development A Textbook | File size: 4 MB | Format: PDF | Categories: Basic Sciences \u0026gt; Immunology \u0026gt; Viral Vectors in Veterinary Vaccine Development: A Textbook\u003c\/p\u003e\u003cp\u003eDigital veterinary textbook. Instant download after purchase.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eSave 30% — Limited time offer!\u003c\/strong\u003e\u003c\/p\u003e\n\n\u003ch3\u003eTable of Contents\u003c\/h3\u003e\n\u003cdiv class=\"gvc-locked-preview\"\u003e\n  \u003cdiv class=\"gvc-locked-icon\"\u003e🔒\u003c\/div\u003e\n  \u003ch3\u003eSample Preview\u003c\/h3\u003e\n  \u003cp\u003eThe full PDF is available after purchase. Instant download. Lifetime access. Read on any device.\u003c\/p\u003e\n  \u003cp class=\"gvc-locked-meta\"\u003eTrusted by 4,000+ veterinary professionals worldwide.\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cul\u003e\n  \u003cli\u003eContributors (p.10)\u003c\/li\u003e\n  \u003cli\u003e1 Evaluation and triage of the critically ill patient (p.27)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.32)\u003c\/li\u003e\n  \u003cli\u003e2 Physical examination and daily assessment of the critically ill patient (p.35)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.40)\u003c\/li\u003e\n  \u003cli\u003e3 Hemostasis (p.41)\u003c\/li\u003e\n  \u003cli\u003e1 Initiation: (p.41)\u003c\/li\u003e\n  \u003cli\u003e2 Extension: (p.42)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.46)\u003c\/li\u003e\n  \u003cli\u003e4 Cardiopulmonary resuscitation (p.48)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.53)\u003c\/li\u003e\n  \u003cli\u003e5 Postcardiac arrest care (p.56)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.61)\u003c\/li\u003e\n  \u003cli\u003e6 Classification and initial management of shock states (p.63)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.67)\u003c\/li\u003e\n  \u003cli\u003e7 SIRS, MODS, and sepsis (p.68)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.73)\u003c\/li\u003e\n  \u003cli\u003e8 Oxygen toxicity (p.75)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.79)\u003c\/li\u003e\n  \u003cli\u003e9 The endothelial surface layer (p.81)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.85)\u003c\/li\u003e\n  \u003cli\u003e10 Hyperthermia and fever (p.87)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.92)\u003c\/li\u003e\n  \u003cli\u003e11 Interstitial edema (p.93)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.97)\u003c\/li\u003e\n  \u003cli\u003e12 Patient suffering in the intensive care unit (p.98)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.100)\u003c\/li\u003e\n  \u003cli\u003e13 Predictive scoring systems in veterinary medicine (p.101)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.104)\u003c\/li\u003e\n  \u003cli\u003e14 Control of breathing (p.106)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.110)\u003c\/li\u003e\n  \u003cli\u003e15 Oxygen therapy (p.111)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.114)\u003c\/li\u003e\n  \u003cli\u003e16 Hypoxemia (p.115)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.120)\u003c\/li\u003e\n  \u003cli\u003e17 Hypoventilation (p.121)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.126)\u003c\/li\u003e\n  \u003cli\u003e18 Upper airway disease (p.127)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.135)\u003c\/li\u003e\n  \u003cli\u003e19 Tracheal collapse: Management \u0026amp; indications for tracheal stents (p.139)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.144)\u003c\/li\u003e\n  \u003cli\u003e20 Feline bronchopulmonary disease (p.145)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.147)\u003c\/li\u003e\n  \u003cli\u003e21 Lower airway disease in dogs (p.148)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.151)\u003c\/li\u003e\n  \u003cli\u003e22 Pulmonary hypertension (p.153)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.157)\u003c\/li\u003e\n  \u003cli\u003e23 Pulmonary edema (p.158)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.162)\u003c\/li\u003e\n  \u003cli\u003e24 Pneumonia (p.164)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.172)\u003c\/li\u003e\n  \u003cli\u003e25 Acute respiratory distress syndrome (p.175)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.178)\u003c\/li\u003e\n  \u003cli\u003e26 Pulmonary contusions and hemorrhage (p.180)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.185)\u003c\/li\u003e\n  \u003cli\u003e27 Pulmonary thromboembolism (p.187)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.190)\u003c\/li\u003e\n  \u003cli\u003e28 Chest wall disease (p.192)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.195)\u003c\/li\u003e\n  \u003cli\u003e29 Pleural space disease (p.197)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.202)\u003c\/li\u003e\n  \u003cli\u003e30 Respiratory distress look-alikes (p.204)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.206)\u003c\/li\u003e\n  \u003cli\u003e31 High flow nasal oxygen (p.208)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.210)\u003c\/li\u003e\n  \u003cli\u003e32 Mechanical ventilationcore concepts (p.212)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.219)\u003c\/li\u003e\n  \u003cli\u003e33 Mechanical ventilationadvanced concepts (p.220)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.223)\u003c\/li\u003e\n  \u003cli\u003e34 Jet ventilation (p.225)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.227)\u003c\/li\u003e\n  \u003cli\u003e35 Ventilator waveforms (p.228)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.237)\u003c\/li\u003e\n  \u003cli\u003e36 Anesthesia and monitoring of the ventilator patient (p.239)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.244)\u003c\/li\u003e\n  \u003cli\u003e37 Nursing care of the ventilator patient (p.246)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.249)\u003c\/li\u003e\n  \u003cli\u003e38 Discontinuing mechanical ventilation (p.250)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.253)\u003c\/li\u003e\n  \u003cli\u003e39 Ventilator-induced lung injury (p.254)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.257)\u003c\/li\u003e\n  \u003cli\u003e40 Ventilator-associated pneumonia (p.259)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.263)\u003c\/li\u003e\n  \u003cli\u003e41 Mechanisms of heart failure (p.265)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.269)\u003c\/li\u003e\n  \u003cli\u003e42 Ventricular failure and myocardial infarction (p.270)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.272)\u003c\/li\u003e\n  \u003cli\u003e43 Feline cardiomyopathy (p.273)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.279)\u003c\/li\u003e\n  \u003cli\u003e44 Canine cardiomyopathy (p.282)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.285)\u003c\/li\u003e\n  \u003cli\u003e45 Canine myxomatous mitral valve disease (p.287)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.291)\u003c\/li\u003e\n  \u003cli\u003e46 Blunt cardiac injury (p.293)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.296)\u003c\/li\u003e\n  \u003cli\u003e47 Pericardial diseases (p.298)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.305)\u003c\/li\u003e\n  \u003cli\u003e48 Bradyarrhythmias and conduction disturbances (p.306)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.309)\u003c\/li\u003e\n  \u003cli\u003e49 Supraventricular tachyarrhythmias (p.310)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.316)\u003c\/li\u003e\n  \u003cli\u003e50 Ventricular tachyarrhythmias (p.318)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.322)\u003c\/li\u003e\n  \u003cli\u003e51 Myocarditis (p.323)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.325)\u003c\/li\u003e\n  \u003cli\u003e52 Cardiac biomarkers (p.327)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.329)\u003c\/li\u003e\n  \u003cli\u003e53 Systemic hypertension (p.331)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.334)\u003c\/li\u003e\n  \u003cli\u003e54 Cardiopulmonary bypass (p.336)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.341)\u003c\/li\u003e\n  \u003cli\u003e55 Sodium disorders (p.343)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.351)\u003c\/li\u003e\n  \u003cli\u003e56 Potassium disorders (p.353)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.358)\u003c\/li\u003e\n  \u003cli\u003e57 Calcium disorders (p.360)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.366)\u003c\/li\u003e\n  \u003cli\u003e58 Magnesium and phosphate disorders (p.369)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.375)\u003c\/li\u003e\n  \u003cli\u003e59 Traditional acid-base analysis (p.377)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.382)\u003c\/li\u003e\n  \u003cli\u003e60 Nontraditional acid-base analysis (p.384)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.388)\u003c\/li\u003e\n  \u003cli\u003e61 Hyperlactatemia (p.389)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.393)\u003c\/li\u003e\n  \u003cli\u003e62 Urine osmolality and electrolytes (p.396)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.399)\u003c\/li\u003e\n  \u003cli\u003e63 Assessment of hydration (p.400)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.403)\u003c\/li\u003e\n  \u003cli\u003e64 Assessment of intravascular volume (p.405)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.411)\u003c\/li\u003e\n  \u003cli\u003e65 Crystalloids and hemoglobin-based oxygen-carrying solutions (p.413)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.416)\u003c\/li\u003e\n  \u003cli\u003e66 Colloid solutions (p.418)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.421)\u003c\/li\u003e\n  \u003cli\u003e67 Daily intravenous fluid therapy (p.423)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.427)\u003c\/li\u003e\n  \u003cli\u003e68 Shock fluids and fluid challenge (p.429)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.433)\u003c\/li\u003e\n  \u003cli\u003e69 Transfusion medicine (p.436)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.441)\u003c\/li\u003e\n  \u003cli\u003e70 Blood types, pretransfusion compatibility, and transfusion reactions (p.443)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.447)\u003c\/li\u003e\n  \u003cli\u003e71 Hemorrhagic shock (p.449)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.454)\u003c\/li\u003e\n  \u003cli\u003e72 The diabetic patient in the ICU (p.456)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.458)\u003c\/li\u003e\n  \u003cli\u003e73 Diabetic ketoacidosis (p.459)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.463)\u003c\/li\u003e\n  \u003cli\u003e74 Hyperglycemic hyperosmolar syndrome (p.465)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.469)\u003c\/li\u003e\n  \u003cli\u003e75 Hypoglycemia (p.471)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.476)\u003c\/li\u003e\n  \u003cli\u003e76 Diabetes insipidus (p.478)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.480)\u003c\/li\u003e\n  \u003cli\u003e77 Syndrome of inappropriate antidiuretic hormone secretion (p.481)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.483)\u003c\/li\u003e\n  \u003cli\u003e78 Thyroid storm (p.484)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.487)\u003c\/li\u003e\n  \u003cli\u003e79 Hypothyroid crisis in the dog (p.488)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.490)\u003c\/li\u003e\n  \u003cli\u003e80 Pheochromocytoma (p.492)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.495)\u003c\/li\u003e\n  \u003cli\u003e81 Critical illness-related corticosteroid insufficiency (p.497)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.500)\u003c\/li\u003e\n  \u003cli\u003e82 Hypoadrenocorticism (p.502)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.505)\u003c\/li\u003e\n  \u003cli\u003e83 Neurological evaluation of the ICU patient (p.507)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.515)\u003c\/li\u003e\n  \u003cli\u003e84 Seizures and status epilepticus (p.517)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.521)\u003c\/li\u003e\n  \u003cli\u003e85 Intracranial hypertension (p.522)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.528)\u003c\/li\u003e\n  \u003cli\u003e86 Tetanus (p.530)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.533)\u003c\/li\u003e\n  \u003cli\u003e87 Hepatic encephalopathy (p.535)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.537)\u003c\/li\u003e\n  \u003cli\u003e88 Hospital-associated infections and zoonoses (p.539)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.541)\u003c\/li\u003e\n  \u003cli\u003e89 Febrile neutropenia (p.542)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.546)\u003c\/li\u003e\n  \u003cli\u003e90 Sepsis and septic shock (p.548)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.553)\u003c\/li\u003e\n  \u003cli\u003e91 Bacterial infections (p.556)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.559)\u003c\/li\u003e\n  \u003cli\u003e92 Fungal infections (p.561)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.565)\u003c\/li\u003e\n  \u003cli\u003e93 Viral infections (p.567)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.572)\u003c\/li\u003e\n  \u003cli\u003e94 Canine parvovirus infection (p.573)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.576)\u003c\/li\u003e\n  \u003cli\u003e95 Infective endocarditis (p.578)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.584)\u003c\/li\u003e\n  \u003cli\u003e96 Urosepsis (p.586)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.591)\u003c\/li\u003e\n  \u003cli\u003e97 Necrotizing soft tissue infections (p.593)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.596)\u003c\/li\u003e\n  \u003cli\u003e98 Catheter-related bloodstream infections (p.598)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.603)\u003c\/li\u003e\n  \u003cli\u003e99 Multidrug-resistant infections (p.605)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.607)\u003c\/li\u003e\n  \u003cli\u003e100 Infectious disease control in the ICU (p.609)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.612)\u003c\/li\u003e\n  \u003cli\u003e101 Hypercoagulable states (p.613)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.619)\u003c\/li\u003e\n  \u003cli\u003e102 Feline aortic thromboembolism (p.624)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.627)\u003c\/li\u003e\n  \u003cli\u003e103 Platelet disorders (p.628)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.635)\u003c\/li\u003e\n  \u003cli\u003e104 Coagulopathy in the ICU (p.637)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.643)\u003c\/li\u003e\n  \u003cli\u003e105 Management of the bleeding patient in the ICU (p.644)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.646)\u003c\/li\u003e\n  \u003cli\u003e106 Anemia in the ICU (p.648)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.652)\u003c\/li\u003e\n  \u003cli\u003e107 Dyshemoglobinemias (p.653)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.659)\u003c\/li\u003e\n  \u003cli\u003e108 Acute hemolytic disorders (p.661)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.667)\u003c\/li\u003e\n  \u003cli\u003e109 Acute abdominal pain (p.669)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.672)\u003c\/li\u003e\n  \u003cli\u003e110 Acute pancreatitis (p.673)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.678)\u003c\/li\u003e\n  \u003cli\u003e111 Acute cholecystitis (p.680)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.683)\u003c\/li\u003e\n  \u003cli\u003e112 Hepatitis and cholangiohepatitis (p.684)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.688)\u003c\/li\u003e\n  \u003cli\u003e113 Hepatic failure (p.689)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.695)\u003c\/li\u003e\n  \u003cli\u003e114 Portal hypertension (p.697)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.702)\u003c\/li\u003e\n  \u003cli\u003e115 Portosystemic shunt management (p.704)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.707)\u003c\/li\u003e\n  \u003cli\u003e116 Acute gastroenteritis (p.709)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.713)\u003c\/li\u003e\n  \u003cli\u003e117 Gastrointestinal hemorrhage (p.714)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.718)\u003c\/li\u003e\n  \u003cli\u003e118 Regurgitation and vomiting (p.720)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.724)\u003c\/li\u003e\n  \u003cli\u003e119 Diarrhea (p.725)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.728)\u003c\/li\u003e\n  \u003cli\u003e120 Peritonitis (p.730)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.733)\u003c\/li\u003e\n  \u003cli\u003e121 Acute kidney injury (p.735)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.740)\u003c\/li\u003e\n  \u003cli\u003e122 Chronic kidney disease (p.742)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.748)\u003c\/li\u003e\n  \u003cli\u003e123 Kidney transplantation (p.750)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.756)\u003c\/li\u003e\n  \u003cli\u003e124 Nutritional assessment (p.758)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.763)\u003c\/li\u003e\n  \u003cli\u003e125 Nutritional modulation of critical illness (p.764)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.767)\u003c\/li\u003e\n  \u003cli\u003e126 Enteral nutrition (p.769)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.773)\u003c\/li\u003e\n  \u003cli\u003e127 Parenteral nutrition (p.775)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.778)\u003c\/li\u003e\n  \u003cli\u003e128 Traumatic brain injury (p.780)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.784)\u003c\/li\u003e\n  \u003cli\u003e129 Wound management (p.785)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.792)\u003c\/li\u003e\n  \u003cli\u003e130 Thermal burn injury (p.794)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.798)\u003c\/li\u003e\n  \u003cli\u003e131 Pain assessment (p.799)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.803)\u003c\/li\u003e\n  \u003cli\u003e132 Sedation of the critically ill patient (p.805)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.806)\u003c\/li\u003e\n  \u003cli\u003e133 Anesthesia in the critically ill patient (p.807)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.814)\u003c\/li\u003e\n  \u003cli\u003e134 Analgesia and constant rate infusions (p.816)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.822)\u003c\/li\u003e\n  \u003cli\u003e135 Physical rehabilitation for the critical care patient (p.824)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.828)\u003c\/li\u003e\n  \u003cli\u003e136 Integrative veterinary medicine for the intensive care unit patient (p.830)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.832)\u003c\/li\u003e\n  \u003cli\u003e137 Smoke inhalation (p.834)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.838)\u003c\/li\u003e\n  \u003cli\u003e138 Hypothermia (p.840)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.845)\u003c\/li\u003e\n  \u003cli\u003e139 Heat stroke (p.847)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.850)\u003c\/li\u003e\n  \u003cli\u003e140 Drowning and submersion injury (p.852)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.854)\u003c\/li\u003e\n  \u003cli\u003e141 Anaphylaxis (p.856)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.860)\u003c\/li\u003e\n  \u003cli\u003e142 Gas embolism (p.861)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.864)\u003c\/li\u003e\n  \u003cli\u003e143 Subcutaneous emphysema (p.865)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.868)\u003c\/li\u003e\n  \u003cli\u003e144 Ocular disease in the intensive care unit (p.870)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.874)\u003c\/li\u003e\n  \u003cli\u003e145 Critically ill neonatal and pediatric patients (p.875)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.879)\u003c\/li\u003e\n  \u003cli\u003e146 Critically ill geriatric patients (p.881)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.884)\u003c\/li\u003e\n  \u003cli\u003e147 Catecholamines (p.885)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.889)\u003c\/li\u003e\n  \u003cli\u003e148 Vasopressin (p.891)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.895)\u003c\/li\u003e\n  \u003cli\u003e149 Antihypertensives (p.897)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.901)\u003c\/li\u003e\n  \u003cli\u003e150 Pimobendan (p.902)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.905)\u003c\/li\u003e\n  \u003cli\u003e151 Diuretics (p.907)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.911)\u003c\/li\u003e\n  \u003cli\u003e152 Appetite stimulants (p.912)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.914)\u003c\/li\u003e\n  \u003cli\u003e153 Gastrointestinal protectants (p.916)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.918)\u003c\/li\u003e\n  \u003cli\u003e154 Antiemetics and prokinetics (p.920)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.923)\u003c\/li\u003e\n  \u003cli\u003e155 Opioid agonists and antagonists (p.925)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.930)\u003c\/li\u003e\n  \u003cli\u003e156 Benzodiazepines (p.932)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.934)\u003c\/li\u003e\n  \u003cli\u003e157 α₂-agonists and antagonists (p.935)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.937)\u003c\/li\u003e\n  \u003cli\u003e158 Nonsteroidal antiinflammatory drugs (p.941)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.947)\u003c\/li\u003e\n  \u003cli\u003e159 Gabapentin (p.949)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.951)\u003c\/li\u003e\n  \u003cli\u003e160 Tramadol (p.952)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.954)\u003c\/li\u003e\n  \u003cli\u003e161 Trazodone (p.955)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.956)\u003c\/li\u003e\n  \u003cli\u003e162 Cannabinoid medicine in intensive care unit patients (p.958)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.961)\u003c\/li\u003e\n  \u003cli\u003e163 Anticonvulsants (p.962)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.965)\u003c\/li\u003e\n  \u003cli\u003e164 Antiplatelet drugs (p.967)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.971)\u003c\/li\u003e\n  \u003cli\u003e165 Anticoagulants (p.973)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.979)\u003c\/li\u003e\n  \u003cli\u003e166 Thrombolytic agents (p.981)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.984)\u003c\/li\u003e\n  \u003cli\u003e167 Hemostatic drugs (p.986)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.989)\u003c\/li\u003e\n  \u003cli\u003e168 Antiarrhythmic agents (p.991)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.995)\u003c\/li\u003e\n  \u003cli\u003e169 Inhaled medications (p.997)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1001)\u003c\/li\u003e\n  \u003cli\u003e170 Complications of chemotherapy agents (p.1002)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1006)\u003c\/li\u003e\n  \u003cli\u003e171 Antitoxins and antivenoms (p.1008)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1011)\u003c\/li\u003e\n  \u003cli\u003e172 Antimicrobial use in the critical care patient (p.1013)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1019)\u003c\/li\u003e\n  \u003cli\u003e173 β-lactam antimicrobials (p.1021)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1023)\u003c\/li\u003e\n  \u003cli\u003e174 Aminoglycosides (p.1025)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1029)\u003c\/li\u003e\n  \u003cli\u003e175 Fluoroquinolones (p.1031)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1035)\u003c\/li\u003e\n  \u003cli\u003e176 Antifungal therapy (p.1037)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1040)\u003c\/li\u003e\n  \u003cli\u003e177 Miscellaneous antibiotics (p.1041)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1045)\u003c\/li\u003e\n  \u003cli\u003e178 Renal replacement therapies (p.1047)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1050)\u003c\/li\u003e\n  \u003cli\u003e179 Apheresis (p.1052)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1054)\u003c\/li\u003e\n  \u003cli\u003e180 Extracorporeal therapies for blood purification (p.1056)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1059)\u003c\/li\u003e\n  \u003cli\u003e181 Hemodynamic monitoring (p.1060)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1065)\u003c\/li\u003e\n  \u003cli\u003e182 Cardiac output monitoring (p.1067)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1071)\u003c\/li\u003e\n  \u003cli\u003e183 Electrocardiogram evaluation (p.1073)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1078)\u003c\/li\u003e\n  \u003cli\u003e184 Oximetry monitoring (p.1079)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1082)\u003c\/li\u003e\n  \u003cli\u003e185 Colloid osmotic pressure and osmolality (p.1084)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1088)\u003c\/li\u003e\n  \u003cli\u003e186 Coagulation and platelet monitoring (p.1089)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1093)\u003c\/li\u003e\n  \u003cli\u003e187 Viscoelastic monitoring (p.1094)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1099)\u003c\/li\u003e\n  \u003cli\u003e188 Intraabdominal pressure monitoring (p.1101)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1104)\u003c\/li\u003e\n  \u003cli\u003e189 Point-of-care ultrasound in the ICU (p.1106)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1121)\u003c\/li\u003e\n  \u003cli\u003e190 Capnography (p.1123)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1126)\u003c\/li\u003e\n  \u003cli\u003e191 Intracranial pressure monitoring (p.1127)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1131)\u003c\/li\u003e\n  \u003cli\u003e192 Urine output (p.1133)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1136)\u003c\/li\u003e\n  \u003cli\u003e193 Peripheral venous catheterization (p.1137)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1141)\u003c\/li\u003e\n  \u003cli\u003e194 Intraosseous catheterization (p.1142)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1146)\u003c\/li\u003e\n  \u003cli\u003e195 Central venous catheterization (p.1147)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1153)\u003c\/li\u003e\n  \u003cli\u003e196 Blood film evaluation (p.1155)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1160)\u003c\/li\u003e\n  \u003cli\u003e197 Endotracheal intubation and tracheostomy (p.1161)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1165)\u003c\/li\u003e\n  \u003cli\u003e198 Thoracocentesis (p.1167)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1170)\u003c\/li\u003e\n  \u003cli\u003e199 Thoracostomy tube placement and drainage (p.1172)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1176)\u003c\/li\u003e\n  \u003cli\u003e200 Abdominocentesis (p.1177)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1179)\u003c\/li\u003e\n  \u003cli\u003e201 Arterial catheterization (p.1180)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1183)\u003c\/li\u003e\n  \u003cli\u003e202 Blood gas sampling (p.1184)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1186)\u003c\/li\u003e\n  \u003cli\u003e203 Temporary cardiac pacing (p.1188)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1193)\u003c\/li\u003e\n  \u003cli\u003e204 Cardioversion (p.1194)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1196)\u003c\/li\u003e\n  \u003cli\u003e205 Defibrillation (p.1197)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1199)\u003c\/li\u003e\n  \u003cli\u003e206 Cerebrospinal fluid sampling and interpretation (p.1200)\u003c\/li\u003e\n  \u003cli\u003e1 Preparation for CSF tap (p.1201)\u003c\/li\u003e\n  \u003cli\u003e2 CSF collection sites and techniques (p.1201)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1205)\u003c\/li\u003e\n  \u003cli\u003e207 Urinary catheterization (p.1207)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1211)\u003c\/li\u003e\n  \u003cli\u003e208 Urinary diversion techniques (p.1213)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1217)\u003c\/li\u003e\n  \u003cli\u003e209 Intensive care unit facility design (p.1219)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1226)\u003c\/li\u003e\n  \u003cli\u003e210 Management of the intensive care unit (p.1228)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1231)\u003c\/li\u003e\n  \u003cli\u003e211 Client communication, grief, and veterinary wellness (p.1232)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1235)\u003c\/li\u003e\n  \u003cli\u003e212 Prevention of compassion fatigue and burnout (p.1237)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.1242)\u003c\/li\u003e\n  \u003cli\u003eIndex (p.1250)\u003c\/li\u003e\n  \u003cli\u003e\u003cem\u003e... and 3151 more chapters\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003cdiv style=\"margin:20px 0;\"\u003e\n\u003ch3\u003ePreview This Book (First 20 Pages)\u003c\/h3\u003e\n\n\u003cp style=\"font-size:12px;color:#666;margin-top:4px;\"\u003eScroll through the preview above to see the first 20 pages of this book.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e🔗 Download Link:\u003c\/strong\u003e \u003c\/p\u003e","brand":"Global Vet \u0026 Co","offers":[{"title":"Default Title","offer_id":51227072659771,"sku":null,"price":200.0,"currency_code":"HKD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0948\/3062\/5083\/files\/viral-vectors-in-veterinary-vaccine-development-a-textbook_HD.png?v=1780508989","url":"https:\/\/globalvetco.com\/zh\/products\/viral-vectors-in-veterinary-vaccine-development-a-textbook","provider":"Global Vet \u0026 Co Ltd","version":"1.0","type":"link"}